betulinic acid and imatinib mesylate

betulinic acid has been researched along with imatinib mesylate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fang, Q; Lu, T; Ma, D; Wang, J; Wei, D; Xiong, J; Yu, K1

Other Studies

2 other study(ies) available for betulinic acid and imatinib mesylate

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Betulinic acid restores imatinib sensitivity in BCR-ABL1 kinase-independent, imatinib-resistant chronic myeloid leukemia by increasing HDAC3 ubiquitination and degradation.
    Annals of the New York Academy of Sciences, 2020, Volume: 1467, Issue:1

    Topics: Adult; Apoptosis; Betulinic Acid; Bone Marrow Cells; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Histone Deacetylases; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pentacyclic Triterpenes; Signal Transduction; Triterpenes; Ubiquitination; Young Adult

2020